Assessing the clinical utility of a calculated Survival Score Index for Implantable Cardioverter Defibrillator (ICD) patients having had device battery replacement or palliative care at an Australian tertiary hospital - SUSCI-AUS study
Not Applicable
- Conditions
- heart rhythm disordersCardiac Implanted Electronic DevicesCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12621001553864
- Lead Sponsor
- A/Prof Dennis Lau
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Implantable Cardioverter Defibrillator insitu which between January 1st 2015 to December 31st 2020 had at the Royal Adelaide Hospital an intervention of battery replacement or elective palliative deactivation performed.
Exclusion Criteria
Cardiac Implantable Electronic Device is does not have Implantable Cardioverter Defibrillator function, or the intervention on the device was performed elsewhere.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of the survival scores, which are calculated individually for each patient from retrospective analysis of existing clinical data, and then combined for grouped analysis according to the intervention of either an Implantable Cardioverter Defibrillator battery replacement, or an elective palliative device deactivation.[Assessed from hospital medical records which will be collected up until 5 August 2022 for Implantable Cardioverter Defibrillator patients at Royal Adelaide Hospital who had intervention of either a device battery replacement, or an elective palliative device deactivation between 1st January 2015 to 31st December 2020.]
- Secondary Outcome Measures
Name Time Method Comparison of the basic clinical parameters (ie; age, gender, heart failure classification) recorded for each patient obtained from retrospective analysis of existing clinical records, and then combined for grouped analysis according to the intervention of either an Implantable Cardioverter Defibrillator battery replacement, or an elective palliative device deactivation.[Assessed from hospital medical records which will be collected up until 5 August 2022 for Implantable Cardioverter Defibrillator patients at Royal Adelaide Hospital who had intervention of either a device battery replacement, or an elective palliative device deactivation between 1st January 2015 to 31st December 2020.]